Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2009 - 2026)

Johnson & Johnson (JNJ) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $200.9 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 3.73% year-over-year to $200.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $786.3 billion (up 7.25% YoY) and the FY2025 annual result came in at $199.2 billion, up 10.61% from the prior year.
• Liabilities and Shareholders Equity rose to $200.9 billion in Q1 2026 per JNJ's latest filing, from $199.2 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $200.9 billion in Q1 2026, with the low at $166.1 billion in Q4 2023.
• Average Liabilities and Shareholders Equity over 5 years is $184.1 billion, with a median of $181.6 billion recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity declined 12.25% in 2024 and increased 12.62% in 2025.
• Johnson & Johnson's Liabilities and Shareholders Equity stood at $175.1 billion in 2022, then dropped by 4.32% to $167.6 billion in 2023, then grew by 7.49% to $180.1 billion in 2024, then grew by 10.61% to $199.2 billion in 2025, then advanced by 0.85% to $200.9 billion in 2026.
• Business Quant data shows JNJ's Liabilities and Shareholders Equity at $200.9 billion in Q1 2026, $199.2 billion in Q4 2025, and $192.8 billion in Q3 2025.